TRAF1 is a negative regulator of TNF signaling: Enhanced TNF signaling in TRAF1-deficient mice

Immunity

Volumn 15, Issue 4, 2001, Pages 647-657

  Tsitsikov, Erdyni N ^a   Laouini, Dhafer ^a   Dunn, Ian F ^a   Sannikova, Tatyana Y ^a   Davidson, Laurie ^a   Alt, Frederick W ^a   Geha, Raif S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PROTEIN; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION; SKIN ALLERGY; SKIN NECROSIS;

EID: 0034752285     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00207-2     Document Type: Article

References (63)

1. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: Changes in TNF-alpha receptor expression and activation of caspases
2. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase
3. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1
4. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
5. TRAF1 is a TNF inducible regulator of NF-kappaB activation
6. Soluble TNF receptor production by activated T lymphocytes: Differential effects of acute and chronic exposure to TNF
7. Structure of the murine TRAF1 gene
8. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
9. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand
10. Ox-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses
11. CD27 is required for generation and long-term maintenance of T cell immunity
12. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation
13. CD30: Expression and function in health and disease
14. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28
15. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
16. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis
17. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B
18. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B
19. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF- kappaB activation
20. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection
21. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand
22. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice
23. TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-a induced apoptosis
24. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
25. Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo
26. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP- 1
27. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion
28. Mechanisms of peripheral T cell deletion: Anergized T cells are Fas resistant but undergo proliferation-associated apoptosis
29. Delayed kinetics of T lymphocyte anergy and deletion in lpr mice
30. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
31. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
32. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice
33. Targeted disruption of Traf5 gene causes defects in CD40- and CD27- mediated lymphocyte activation
34. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses
35. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice
36. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
37. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization
38. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
39. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4
40. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4- 1BB ligand
41. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: Induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses
42. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase
43. Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice
44. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: Identification of a novel in vivo role for p75
45. TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs
46. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
47. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice
48. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation
49. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells
50. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice
51. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice
52. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal
53. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response
54. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2
55. Clonal deletion as direct consequence of an in vivo T cell response to bacterial superantigen
56. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation
57. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor
58. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses
59. NF-kappaB activation in CD27 signaling: Involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27
60. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors
61. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
62. TNFR-Associated factor family protein expression in normal tissues and lymphoid malignancies
63. Induction of apoptosis in mature T cells by tumour necrosis factor